2nd Annual Cell Culture Congress 2013

Experts predict that the cell culture sector will be worth over $6 billion by 2015. The growth of the biopharma industry as whole, combined with the increasingly wide reach of cell culture applications has secured a prominent role for cell culture and bioprocessing in the pharmaceutical industry of the future.
This event is designed to offer clear and informed insights into the trends and solutions most relevant to those working in the industry. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.
On Day One, our panel of cell engineering experts will discuss vector design, genome engineering and high throughput technologies. Delegates will also hear from those working at the forefront of process innovation, in areas such as disposable reactors, next generation fermentation and process characterisation.
Day Two will feature presentations covering the critical opportunities in cell line optimisation including, miniaturised systems, 3D cell culture and bioinformatic analysis. Our highly esteemed speakers will also explore the key challenges in biological production; topics will include CMO relationship management, technology transfer and the role of single-use technology.
The Cell Culture & Bioprocessing Congress is part of the highly successful Oxford Global Proteins Series.
For more information click here